Emcure Pharmaceuticals receives warning letter from FDA
A warning letter has been sent to Emcure Pharmaceuticals after an FDA facility inspection found that the company did not adequately investigate sterility failures.
August 21, 2019
by europeanpharmaceuticalreview
Teva shares approach 20-year low amid Moody's warning and other woes
Teva Pharmaceutical CEO Kåre Schultz has gone to great lengths to shave off $3 billion in costs by instituting a major restructuring plan that has included slashing 14,000 jobs and shuttering manufacturing plants around the world.
August 18, 2019
by fiercepharma
FDA Sending Warning to Curaleaf for Marketing Unapproved Cannabidiol Products
The U.S. Food and Drug Administration (FDA) has issued a warning letter to Curaleaf Inc., of Wakefield, Massachusetts, for illegally selling unapproved products containing cannabidiol (CBD) online with ...
July 26, 2019
by americanpharmaceuticalreview
FDA issues three warning letters to API re-packers
Three API re-packers who failed to meet current good manufacturing practice requirements have received warning letters from the FDA.
July 4, 2019
by europeanpharmaceuticalreview
Sugary Sodas Still Popular, But Warnings, Taxes Can Curb Uptake
Sugary Sodas Still Popular, But Warnings, Taxes Can Curb Uptake.
June 10, 2019
by drugs
FDA pushes for stronger warnings on insomnia medicines
FDA pushes for stronger warnings on insomnia medicines.
May 10, 2019
by pharmatimes
FDA warning slams St Jude's "inadequate response" to device failures
St Jude Medical has been hit with a warning letter from the FDA over the medical device manufacturer’s failure to address issues with its implantable defibrillators and at-home monitoring equipment.
April 14, 2017
by pharmafile